Pancreas Cancer News and Archives
	PEFG (Cisplatin, Epirubicin, 5-Fluorouracil, Gemcitabine) Regimen as Second-Line Therapy in Patients with Progressive or Recurrent Pancreatic Cancer after Gemcitabine-Containing Chemotherapy April 1, 2008 Am J Clin Oncol. 2008 Apr;31(2):145-50. PMID: 18391598 [Abstract]
	For educational purposes only; not to be relied upon Please read Pancreatica Disclaimer
	Home | In The News | Links | Donations FAQ | Clinical Trials Database | Research Resources | About Us
	webmaster
	©2000-2008 Pancreatica.org - All Rights Reserved www.pancreatica.org